ALGN vs. BSX: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALGN and BSX, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
BSX stands out with 154.81 billion USD in market value—about 12.42× ALGN’s market cap of 12.46 billion USD.
ALGN’s beta of 1.68 points to much larger expected swings compared to BSX’s calmer 0.69, suggesting both higher upside and downside potential.
| Symbol | ALGN | BSX |
|---|---|---|
| Company Name | Align Technology, Inc. | Boston Scientific Corporation |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Devices |
| CEO | Mr. Joseph M. Hogan | Mr. Michael F. Mahoney |
| Price | 171.91 USD | 104.64 USD |
| Market Cap | 12.46 billion USD | 154.81 billion USD |
| Beta | 1.68 | 0.69 |
| Exchange | NASDAQ | NYSE |
| IPO Date | January 30, 2001 | May 19, 1992 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ALGN and BSX over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ALGN and BSX, please refer to the table below.
| Symbol | ALGN | BSX |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 30.88 | 76.07 |
| Forward PEG Ratio (TTM) | 2.92 | 6.65 |
| Price-to-Sales Ratio (P/S, TTM) | 3.13 | 8.82 |
| Price-to-Book Ratio (P/B, TTM) | 3.33 | 6.96 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 19.76 | 53.88 |
| EV-to-EBITDA (TTM) | 14.56 | 40.53 |
| EV-to-Sales (TTM) | 2.94 | 9.45 |
| EV-to-Free Cash Flow (TTM) | 18.56 | 57.71 |
Dividend Comparison
Neither ALGN nor BSX currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
| Symbol | ALGN | BSX |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ALGN and BSX, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- ALGN shows “--” for interest coverage, hinting at negligible interest costs, whereas BSX (at 13.03) covers its interest obligations.
| Symbol | ALGN | BSX |
|---|---|---|
| Current Ratio (TTM) | 1.21 | 1.45 |
| Quick Ratio (TTM) | 1.08 | 0.88 |
| Debt-to-Equity Ratio (TTM) | 0.03 | 0.53 |
| Debt-to-Assets Ratio (TTM) | 0.02 | 0.29 |
| Interest Coverage Ratio (TTM) | -- | 13.03 |